Overview

This educational initiative will explain the FDA Amendments Act (FDAAA) of 2007 and its implications for health-system pharmacists and pharmacies with emphasis on the essential components of risk evaluation and mitigation strategies (REMS). REMS are necessary to ensure that the benefits of a drug outweighs its potential risks. Health-system pharmacists should play an integral role in implementing and assessing REMS programs within hospitals and components of integrated health systems to improve both medication safety and ensure access to therapeutic options for the patients they serve.

Educational Activities

Choose from among the following continuing pharmacy education (CPE) opportunities to expand your knowledge of FDAAA and REMS

Web-based Activity
Captures the presentations from the live symposium for those unable to attend the Midyear Clinical Meeting and is approved for 2 hours of CPE (Individuals claiming CPE credit for the live symposium are ineligible to claim credit for this activity)
  »  Go to Web-based Activity

e-Newsletters
Updates on emerging information related to FDAAA and REMS. Sign-up to receive the newsletter

Informational Interviews with Faculty
Captures content from interviews conducted in December 2009 during which the faculty discussed important concepts related FDAAA and REMS
  »  Go to Interviews